Study design, materials and methods
Retrospective data was collected between January 2013 till January 2018 (5-year period) in the uro-neurology department. All the patients were diagnosed with OAB identified using clinical history, bladder diaries and cystometography. All patients had failed conservative and medical management in the past. All patients underwent sacral nerve modulation (SNM) at the same unit under a single surgeon. This was carried out using the two-stage approach, with electrode insertion (stage 1) followed by battery insertion (stage 2) if stage one was deemed to be successful. The primary outcome measure was success rate of SNM. This was identified using improvement in quality of life as well as objectively using bladder diaries and flow rate. The failure rate was separated into primary failure after stage 1, true failure of the electrode and secondary failure (after insertion of the battery). Secondary complications were also identified including infection, pain and medical complications.
Interpretation of results
There was significant improvement in OAB in both male and female patients with sacral nerve modulation. The overall infection rate of 3% is an appropriate risk in this surgery.